- Home
- TMDX vs NMRK Comparison
TMDX vs NMRK Comparison
Compare TMDX & NMRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | TMDX | NMRK |
|---|---|---|
| Founded | 1998 | 1929 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Real Estate |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6B | 2.8B |
| IPO Year | 2019 | 2017 |
Fundamental Metrics
Financial Performance| Metric | TMDX | NMRK |
|---|---|---|
| Price | $83.30 | $15.43 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 9 | 5 |
| Target Price | ★ $148.22 | $18.75 |
| AVG Volume (30 Days) | 847.3K | ★ 1.2M |
| Earning Date | 05-05-2026 | 04-30-2026 |
| Dividend Yield | N/A | ★ 0.76% |
| EPS Growth | ★ 382.18 | 100.00 |
| EPS | ★ 0.61 | 0.18 |
| Revenue | $605,494,000.00 | ★ $3,294,024,000.00 |
| Revenue This Year | $24.25 | $12.45 |
| Revenue Next Year | $18.75 | $8.02 |
| P/E Ratio | $144.97 | ★ $87.94 |
| Revenue Growth | ★ 37.13 | 20.29 |
| 52 Week Low | $60.11 | $13.36 |
| 52 Week High | $156.00 | $19.84 |
Technical Indicators
Market Signals| Indicator | TMDX | NMRK |
|---|---|---|
| Relative Strength Index (RSI) | 45.40 | 49.24 |
| Support Level | $66.64 | $15.34 |
| Resistance Level | $95.18 | $16.13 |
| Average True Range (ATR) | 3.49 | 0.44 |
| MACD | -0.96 | 0.01 |
| Stochastic Oscillator | 4.56 | 44.13 |
Price Performance
Historical ComparisonAbout TMDX TransMedics Group Inc.
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System (OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization, and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.
About NMRK Newmark Group Inc.
Newmark Group Inc is a commercial real estate advisory firm. It offers services, including leasing and corporate advisory services, investment sales, commercial mortgage brokerage, appraisal and valuation, project management, and property, among others. Newmark offers a diverse array of integrated services and products designed to meet the full needs of both real estate investors/owners and occupiers. The company provides real estate strategic consulting and systems integration services to CFI's clients including many Fortune and Forbes companies, owner-occupiers, government agencies, healthcare, and higher education clients.